Source: British Heart Foundation
Follow this link for full text
Date of publication: June 2017
Publication type: News item
In a nutshell: A naturally occurring molecule called interleukin-4 may help patients recover from a heart attack, according to research presented at the British Cardiovascular Society (BCS) Conference today. The findings show that heart attack patients with low blood levels of a particular white blood cell, called an eosinophil, have higher death rates in the six months after their heart attack. Researchers have also discovered that treating these patients with a molecule called interleukin-4 (IL-4) may help to reduce these death rates.
Length of publication: 1 webpage
Some important notes: Please contact your local NHS library if you cannot access the full text. Follow this link to find your local NHS library.
Acknowledgement: British Heart Foundation